About this trial
This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient of the LA General gynecologic oncology clinic
Age 18 years or older
Previously obtained the HPV vaccination (initial chatbot evaluation)
Eligible for HPV vaccination (pilot intervention; age <46)
Disqualifiers
Patients who do not speak English or Spanish
Patients who do not provide informed consent
Patient of the LA General gynecologic oncology clinic
Age 18 years or older
Trial population
Patients of the LA General gynecologic oncology clinic who meet the eligibility criteria.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
Trial outcomes
Primary outcomes
Patient Satisfaction Scores
Patients will complete a survey to assess their satisfaction with using an AI chatbot for HPV vaccine counseling.
HPV Vaccination Rate
HPV vaccination rate for patients who received the HPV vaccine counseling with the AI-chatbot
Secondary outcomes
Demographics of patients
Will be analyzed using a qualitative description of the demographics of patients involved in this specific study.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator